Lingering Effects: Hashimoto’s Encephalopathy

Hashimoto's encephalopathy (HE), also known as steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT), is a rare autoimmune disease that remains poorly understood. Here, we report a patient who experienced numerous comatose relapses early in the disease course. Despite...

Descripción completa

Detalles Bibliográficos
Autores principales: Foster, Parker, Craig, Taylor, Jha, Pinky, Dhariwal, Mohan S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374021/
https://www.ncbi.nlm.nih.gov/pubmed/35971349
http://dx.doi.org/10.7759/cureus.26809
_version_ 1784767707591213056
author Foster, Parker
Craig, Taylor
Jha, Pinky
Dhariwal, Mohan S
author_facet Foster, Parker
Craig, Taylor
Jha, Pinky
Dhariwal, Mohan S
author_sort Foster, Parker
collection PubMed
description Hashimoto's encephalopathy (HE), also known as steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT), is a rare autoimmune disease that remains poorly understood. Here, we report a patient who experienced numerous comatose relapses early in the disease course. Despite prolonged corticotherapy, cognitive deficits have persisted through the two-year post-diagnosis follow-up. This case highlights the protracted nature of HE.
format Online
Article
Text
id pubmed-9374021
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-93740212022-08-14 Lingering Effects: Hashimoto’s Encephalopathy Foster, Parker Craig, Taylor Jha, Pinky Dhariwal, Mohan S Cureus Internal Medicine Hashimoto's encephalopathy (HE), also known as steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT), is a rare autoimmune disease that remains poorly understood. Here, we report a patient who experienced numerous comatose relapses early in the disease course. Despite prolonged corticotherapy, cognitive deficits have persisted through the two-year post-diagnosis follow-up. This case highlights the protracted nature of HE. Cureus 2022-07-13 /pmc/articles/PMC9374021/ /pubmed/35971349 http://dx.doi.org/10.7759/cureus.26809 Text en Copyright © 2022, Foster et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Foster, Parker
Craig, Taylor
Jha, Pinky
Dhariwal, Mohan S
Lingering Effects: Hashimoto’s Encephalopathy
title Lingering Effects: Hashimoto’s Encephalopathy
title_full Lingering Effects: Hashimoto’s Encephalopathy
title_fullStr Lingering Effects: Hashimoto’s Encephalopathy
title_full_unstemmed Lingering Effects: Hashimoto’s Encephalopathy
title_short Lingering Effects: Hashimoto’s Encephalopathy
title_sort lingering effects: hashimoto’s encephalopathy
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374021/
https://www.ncbi.nlm.nih.gov/pubmed/35971349
http://dx.doi.org/10.7759/cureus.26809
work_keys_str_mv AT fosterparker lingeringeffectshashimotosencephalopathy
AT craigtaylor lingeringeffectshashimotosencephalopathy
AT jhapinky lingeringeffectshashimotosencephalopathy
AT dhariwalmohans lingeringeffectshashimotosencephalopathy

Ejemplares similares